{"id":97818,"date":"2020-04-03T14:29:40","date_gmt":"2020-04-03T18:29:40","guid":{"rendered":"https:\/\/valorguardians.com\/blog\/?p=97818"},"modified":"2020-04-03T14:29:40","modified_gmt":"2020-04-03T18:29:40","slug":"hydroxychloroquine-rated-most-effective-therapy","status":"publish","type":"post","link":"https:\/\/www.azuse.cloud\/?p=97818","title":{"rendered":"Hydroxychloroquine rated &#8216;most effective therapy&#8217;"},"content":{"rendered":"<p style=\"text-align: center;\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-97819 aligncenter\" src=\"https:\/\/www.azuse.cloud\/wp-content\/uploads\/2020\/04\/covid19-300x168.jpg\" alt=\"\" width=\"386\" height=\"216\" srcset=\"https:\/\/www.azuse.cloud\/wp-content\/uploads\/2020\/04\/covid19-300x168.jpg 300w, https:\/\/www.azuse.cloud\/wp-content\/uploads\/2020\/04\/covid19-500x280.jpg 500w, https:\/\/www.azuse.cloud\/wp-content\/uploads\/2020\/04\/covid19.jpg 625w\" sizes=\"auto, (max-width: 386px) 100vw, 386px\" \/><br \/>\nCOVID-19<\/p>\n<p>Only time will tell if any of the assays, medical equipment or drugs the U.S. Food and Drug Administration is approving for use during the COVID-19 pandemic under Emergency Use Authorization (EUA) will turn out to be ineffective or substandard. Now, the agency issued an EUA for hydroxychloroquine and chloroquine, long-used malaria drugs to treat the illness caused by the novel coronavirus.<\/p>\n<p>Scientists and physicians have been cautious about use of the drug for the disease, while President Trump touted it as a \u201cgame changer.\u201d<\/p>\n<p>Poetrooper sends.<\/p>\n<h3>&#8230;by doctors for coronavirus: Global survey<\/h3>\n<p><strong><em>Drug known for treating malaria used by U.S. doctors mostly for high-risk COVID-19 patients<\/em><\/strong><\/p>\n<p><strong>By Valerie Richardson<\/strong><\/p>\n<blockquote><p>An international poll of more than 6,000 doctors released Thursday found that the antimalarial drug hydroxychloroquine was the most highly rated treatment for the novel coronavirus.<\/p>\n<p>The survey conducted by Sermo, a global health care polling company, of 6,227 physicians in 30 countries found that 37% of those treating COVID-19 patients rated hydroxychloroquine as the \u201cmost effective therapy\u201d from a list of 15 options.<\/p>\n<p>The U.S. Food and Drug Administration gave chloroquine and its next-generation derivative, hydroxychloroquine, emergency-use authorization Monday for treating the novel coronavirus, although the drug was already being used off-label by some doctors and hospitals for COVID-19 patients.<\/p>\n<p>The survey also found that the most commonly prescribed treatments are analgesics (56%), azithromycin (41%) and hydroxychloroquine (33%).<\/p>\n<p>Azithromycin, known by the brand name Zithromax or Z-Pak, was rated the second-most effective therapy at 32%, followed by \u201cnothing,\u201d analgesics (including acetaminophen), anti-HIV drugs and cough medicine.<\/p><\/blockquote>\n<p>Read the rest of the article here: <a href=\"https:\/\/www.washingtontimes.com\/news\/2020\/apr\/2\/hydroxychloroquine-rated-most-effective-therapy-do\/\">Washington Times<\/a><\/p>\n<p>Thanks, Poe.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>COVID-19 Only time will tell if any of the assays, medical equipment or drugs the U.S. &hellip; <a title=\"Hydroxychloroquine rated &#8216;most effective therapy&#8217;\" class=\"hm-read-more\" href=\"https:\/\/www.azuse.cloud\/?p=97818\"><span class=\"screen-reader-text\">Hydroxychloroquine rated &#8216;most effective therapy&#8217;<\/span>Read more<\/a><\/p>\n","protected":false},"author":657,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[484,406,88],"tags":[],"class_list":["post-97818","post","type-post","status-publish","format-standard","hentry","category-covid-19","category-guest-link","category-health-care-debate"],"_links":{"self":[{"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=\/wp\/v2\/posts\/97818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=\/wp\/v2\/users\/657"}],"replies":[{"embeddable":true,"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=97818"}],"version-history":[{"count":1,"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=\/wp\/v2\/posts\/97818\/revisions"}],"predecessor-version":[{"id":97820,"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=\/wp\/v2\/posts\/97818\/revisions\/97820"}],"wp:attachment":[{"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=97818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=97818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.azuse.cloud\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=97818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}